Tania L.Weiss, Ph.D.
Marin Biologic Laboratories, Founder & CEO
From an early age while looking at tree leaves, Tania Weiss was fascinated by cellular biology. At the time she began her college studies at the University of Michigan in Ann Arbor, she did not anticipate that she would have a B.S., M.S. and Ph.D. all in chemistry or biochemistry and would go on to work in academia, commercial consulting and eventually create her own research company.
During her post doctoral training at the Univ. of Chicago and Stanford Univ. eventually leading to a teaching role at UCSF, she published 16 Papers and 32 abstracts. She spoke at numerous Symposiums, Societies and Conferences. She spent 6 years in different Chair positions with the San Francisco BioScience Forum and another 5 years on Committees or as Chairs in the American Assoc. of Pharmaceutical Scientists.
Through these years, Dr. Weiss became clear on what inspired her in science; to participate in a variety of projects and solve the unique scientific challenges each may pose. She chose to jump into the growing movement of CRO outsourcing allowing her expertise to become a part of many projects. In 1995 Dr. Weiss became one of the few female PhD founders of a Contract Research Lab, Marin Biologic Laboratories. Her goal of providing creative, solution based science approaches to up and coming pharmaceutical efforts was a perfect blend of art and science.
Dr. Weiss has gathered a core group of like-minded creative and disciplined scientists to her concierge research laboratory environment. With open scientific communication Marin Biologic provides more than just technical capability, it can provide added insights and stimulate conversations with clients that often save time and money. It is this interactive approach that makes Marin Biologic unique; a PhD Founder, CEO and President with her hand selected lab team that partners with biotech and pharmaceutical companies to speed their raw science through regulatory process.
Peter Ralph, Ph.D.
Marin Biologic Laboratories, Vice President of Scientific Affairs
Distinguished academic career at the Salk Institute for Biological Studies and Memorial Sloan Kettering Cancer Center in immunology, hematopoiesis and cancer biology. Over 120 scientifically reviewed papers and 24 issued patents. Developed and patented method to detect Herceptin, and was the developer of the biometric GLP potency assay for Rituximab. Managed over 100 projects for clients at Marin Biologic Laboratories.
BA, Yale University, Physics
MS, University of California, Berkley CA, Physics
Ph.D., Massachusetts Institute of Technology, Biology
Marin Biologic Laboratories, Novato, CA 2001- Present
Vice President, Scientific Affairs March 2010
Head, Quality Assurance
Genetech Inc., South San Francisco, CA
Senior Scientist, Department of BioAnalytical Sciences
Director, Department of Immunology
Cetus Corporation, Emeryville, CA
Senior Director, Research Division: Head, Immune Suppression Project Manager, M-CSF Project; Senior Scientist, Director, Department of Cell Biology
Sloan-Kettering Institute for Cancer Research, Rye. NY
Associate Member; Associate,
Department of Hematopoiesis
Cornell Medical School, New York, NY
Associate Professor; Assistant Professor